ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SUSAN ERISMAN M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 122

$484K Total Retail Price of All Prescriptions

Rank: 17 out of 122

377 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

8% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,275 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
LEVOTHYROXINE SODIUM 539 466 1 4
SIMVASTATIN 386 315 2 1
OMEPRAZOLE 320 257 3 3
HYDROCHLOROTHIAZIDE 316 279 4 6
AMLODIPINE BESYLATE 287 258 5 7
METOPROLOL SUCCINATE 229 191 6 11
FUROSEMIDE 211 167 7 5
ATENOLOL 201 161 8 10
WARFARIN SODIUM 193 173 9 9
METOPROLOL TARTRATE 192 167 10 8
LISINOPRIL 191 150 11 2
METFORMIN HCL 188 131 12 14
GABAPENTIN 156 96 13 12
DIOVAN 152 127 14 40
LOSARTAN POTASSIUM 120 108 15 17
SERTRALINE HCL 112 94 16 18
ATORVASTATIN CALCIUM 109 80 17 13
POTASSIUM CHLORIDE 102 95 18 22
NEXIUM 101 62 19 32
TRAZODONE HCL 100 82 20 21
LANTUS SOLOSTAR 94 53 21 57
PRAVASTATIN SODIUM 90 78 22 27
CITALOPRAM HBR 89 75 23 15
PEN NEEDLE 79 63 24 98
FAMOTIDINE 74 73 25 58
ALENDRONATE SODIUM 69 69 26 35
DONEPEZIL HCL 68 68 27 25
HYDROCODONE-ACETAMINOPHEN 64 40 S3 28 16
ADVAIR DISKUS 63 58 29 34
PREDNISONE 60 58 30 24
PROAIR HFA 57 41 31 31
CLOPIDOGREL 54 28 32 45
SPIRONOLACTONE 52 47 33 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.